Use of CereGate Therapy for Freezing of Gait in PD
NCT05292794
This study is recruiting at 7 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson Disease
- Freezing of Gait
- Deep Brain Stimulation
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- CereGate Inc.
- Last updated on ClinicalTrials.gov
- May 28, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Kaiser Permanente, KPNC Comprehensive Movement Disorders Program · Redwood City, CA
Colorado · 1
- University of Colorado Anschutz Medical Campus · Aurora, CO
Florida · 1
- University of Miami · Miami, FL
Illinois · 1
- Northwestern University · Chicago, IL
North Carolina · 1
- Wake Forest University · Winston-Salem, NC
Tennessee · 1
- Vanderbilt University Medical Center · Nashville, TN
Washington · 1
- University of Washington · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.